Not long ago, “diet food” usually implied denial: tiny servings, joyless packaging, and the faint moralism of self-control. The GLP-1 era is changing that vocabulary. As of November 2025, KFF found that 18% of U.S. adults had used a GLP-1 drug and 12% were currently taking one. Because these medicines reduce appetite and may bring gastrointestinal side effects, recent clinical guidance from four major professional organizations stresses nutrient-dense, minimally processed diets, adequate protein, fiber, and lifestyle support rather than medication alone. Cleveland Clinic likewise emphasizes protein and fiber as especially important, while warning that high-fat or spicy foods can aggravate symptoms. (kff.org)

The food industry, unsurprisingly, has begun to redesign itself around this new physiology of fullness. Nestlé announced Vital Pursuit in May 2024 as a line for GLP-1 users and weight-management consumers, describing its frozen meals as high in protein, a good source of fiber, and portion-aligned to smaller appetites; the company said the brand would reach the U.S. in the fourth quarter of 2024. Smoothie King followed in October 2024 with a nationwide GLP-1 Support Menu built around smoothies containing at least 20 grams of protein, fiber, and no added sugar. Conagra then moved the idea onto supermarket shelves: starting in January 2025, 26 Healthy Choice meals began carrying an “On Track” badge highlighting products the company calls “GLP-1 friendly.” (nestle.com)

Yet the phrase “GLP-1 friendly” is both revealing and problematic. It reveals how profoundly appetite medicine is reshaping consumer expectations: smaller portions, higher protein, gentler textures, clearer functional claims. But AP reports that the term itself has no FDA regulatory standard, and the USDA has said there is no formal standard for “GLP-1 Friendly,” even though it approved certain labels when paired with specific nutrition statements. In other words, these foods are not pharmaceutical equivalents; they are an attempt to engineer meals for people who feel full sooner and therefore need every bite to work harder. The shift is now important enough that the Institute of Food Technologists hosted a February 2026 webinar on how GLP-1s are rewriting food product development itself. Satiety, once a private sensation, has become a design brief. (apnews.com)